T1	Participants 222 249	patients with schizophrenia
T2	Participants 1097 1113	setting in Japan
T3	Participants 1297 1489	patients with schizophrenia aged 20 years or over who required antipsychotic medication or switching of the current medication to others for reasons such as lack of efficacy and intolerability
